Impact of body mass index on assisted reproductive technology outcomes in patients with polycystic ovary syndrome: a meta-analysis

Linyu Zhang,Ying Feng,Xinrui Sun,Shiqi Yi,Xue Xiao,Fang Ma
DOI: https://doi.org/10.1016/j.rbmo.2024.103849
IF: 4.567
2024-01-28
Reproductive BioMedicine Online
Abstract:The effect of obesity on pregnancy outcomes of assisted reproductive technology (ART) in this specific population of Polycystic ovary syndrome (PCOS) remains unclear. We conducted a meta-analysis of recent studies to probe the effect of being overweight or obese on ART pregnancy outcomes in patients with PCOS. PubMed, Embase, MEDLINE, Scopus, and Web of Science were searched from inception to 22 July 2023 without language restrictions. The main indicators were the rates of live birth, clinical pregnancy, spontaneous abortion, and multiple pregnancy. We analysed ten studies with a combined sample size of 247,845. Among patients with PCOS undergoing ART who were overweight or obese, the live birth rate, clinical pregnancy rate and implantation rate and the number of retrieved oocytes were lower than those of normal-weight, and spontaneous abortion rate higher than those of normal-weight. In patients with PCOS treated with ART, obesity had a lower multiple pregnancy rate and a lower number of mature oocytes than normal-weight. Our data showed that in women with PCOS, being overweight or obese negatively affects pregnancy outcomes with ART. Our meta-analysis may inform guidelines for pregnancy with ART and encourage overweight or obese patients with PCOS to lose weight. Trial registration number: PROSPERO (Registration Number; CRD42023447547).
obstetrics & gynecology,reproductive biology
What problem does this paper attempt to address?